IM Cannabis Regains Nasdaq Compliance, Stock to Remain Listed.

IM Cannabis Corp. has regained compliance with Nasdaq Listing Rule 5550(b)(1) by maintaining stockholders' equity of at least $2,500,000. The company's common stock will continue to be listed and traded on the Nasdaq Capital Market. IM Cannabis is a leading medical cannabis company with operations in Israel and Germany, providing premium products to medical patients in these countries. The company leverages a data-driven approach and a globally sourced product supply chain.

TORONTO and GLIL YAM, Israel, September 5, 2025 /PRNewswire/ -- IM Cannabis Corp. (NASDAQ: IMCC) (the "Company", "IM Cannabis", or "IMC") has regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain stockholders' equity of at least $2,500,000. This compliance allows the company's common stock to continue being listed and traded on the Nasdaq Capital Market [1].

IM Cannabis is a leading medical cannabis company with operations in Israel and Germany, two of the largest medical cannabis markets. The company provides premium cannabis products to medical patients in these countries. IM Cannabis leverages a data-driven approach and a globally sourced product supply chain to deliver high-quality products [1].

The company operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients. It also runs medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs to ensure the safe delivery and quality control of its products throughout the value chain. In Germany, IM Cannabis operates through Adjupharm GmbH, distributing cannabis to pharmacies for medical cannabis patients [1].

Regaining compliance with Nasdaq Listing Rule 5550(b)(1) is a significant milestone for IM Cannabis. It demonstrates the company's ability to meet the stringent financial requirements set by Nasdaq, thereby maintaining its listing status. This achievement is crucial for investors, as it indicates the company's financial health and stability.

IM Cannabis's commitment to responsible growth and compliance with strict regulatory environments is evident in its operations. The company continues to focus on amplifying its commercial and brand power to become a global high-quality cannabis player. As it expands its operations, IM Cannabis will need to navigate various risks and uncertainties, including regulatory changes, competition, and market conditions [1].

References:

[1] https://investors.imcannabis.com/news-events/press-releases/detail/196/im-cannabis-regains-compliance-with-nasdaq-stockholders
[2] https://finance.yahoo.com/news/im-cannabis-regains-compliance-nasdaq-110000840.html